Continuing Nursing Education (CNE) Activities

Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
The Expanding Playbook of Hepatocellular Carcinoma: Examining Scientific Data and Evidence With Your Multidisciplinary Team
Richard S. Finn, MD
13 January, 2020
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Peter Schmid, FRCP, MD, PhD
30 December, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Best Practices for Recognizing & Managing Immune-Related Adverse Events in the Emergency Department: Become Aware, Stay Alert, Change Your Practice, & Keep Patients With Cancer Safe
Evan J. Lipson, MD
27 November, 2019
Credits: 0.75 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Creating an HIV Prevention–Certified Provider Workforce: A Training and Certificate Program Designed to Improve the Competencies of Providers to Deliver Comprehensive HIV Prevention
Donna E. Sweet, MD, AAHIVS, MACP
19 November, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
Robert Coleman, MD
8 November, 2019
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses
Sorayah Bourenane, MSN, RN, CNL / Marianne Davies, DNP, ACNP, AOCNP
29 October, 2019
Credits: 1.00 CNE
Medical Learning Institute, Inc.
The Urologic Nurse Meets the Challenge of Renal Cell Carcinoma: Insights on Patient Care in an Expanding Treatment Landscape
Julia Batten, APRN, MSN, MPH / Virginia J. Seery, MSN, RN, ANP-BC
17 October, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Improving the Diagnosis, Treatment, and Outcomes of Patients With HAP and VAP: A Critical Look at Current Guidelines and New Treatment Options
Andrew F. Shorr, MD, MPH, MBA, FACP, FCCP
17 October, 2019
Credits: 0.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncology Team and Secondary AML: Conversations on New Science and Its Effect on Patient Care
Stephen A. Strickland, MD, MSCI
18 September, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine
Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics
Robert Z. Orlowski, MD, PhD
8 August, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Applying New Insights to Improve Diagnosis and Management of Interstitial Lung Diseases
Amy L. Olson, MD, MSPH
1 August, 2019
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
Expanding Treatment Choices in Mesothelioma: Exploring the Promise of Tumor Treating Fields and Novel Systemic Approaches to Optimize Patient Outcomes
Charles B. Simone, MD, FACRO
29 July, 2019
Credits: 2.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Stories From the Pancreatic Cancer CaseBook: Taking the Road to Improved Outcomes With Modern Therapeutic Concepts and Innovative Treatments
Johanna C. Bendell, MD
22 July, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers
2 July, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Mapping Progress With Immune Checkpoint Inhibitors in Head and Neck Cancer: Expert Views on Immunotherapy as a Component of Multimodal Care
Ezra Cohen, MD, FRCPSC, FASCO
2 July, 2019
Credits: 1.00 CME / CNE / CPE
Medical Learning Institute, Inc.
Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies
Evan J. Lipson, MD
26 June, 2019
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
25 June, 2019
Credits: 1.00 CME / CNE / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
The Emergence of Oral Therapy as a Pillar of Care in B-Cell Lymphoma: Insights and Expert Opinions From the Hematology-Oncology Team
Nathan H. Fowler, MD
21 June, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Expanding Role of Immunotherapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Thoracic Surgeons
Jessica Donington, MD
17 June, 2019
Credits: 1.25 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Elizabeth A. Mittendorf, MD, PhD
3 June, 2019

Pages